Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price fell 11.5% during trading on Friday . The stock traded as low as C$0.27 and last traded at C$0.27. 407,425 shares were traded during mid-day trading, an increase of 105% from the average session volume of 198,342 shares. The stock had previously closed at C$0.31.
Voyageur Pharmaceuticals Stock Performance
The company’s fifty day simple moving average is C$0.20 and its 200 day simple moving average is C$0.17. The company has a quick ratio of 0.84, a current ratio of 0.10 and a debt-to-equity ratio of 4.23. The stock has a market capitalization of C$40.91 million, a price-to-earnings ratio of -25.25 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Recommended Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Defense Leaders Set to Gain From Rising Military Spend
- 5 discounted opportunities for dividend growth investors
- Why the Schwab Dividend ETF Rallied—and Can It Keep Climbing?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MarketBeat Week in Review – 06/30 – 07/04
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
